BD appoints Vitor Roque CFO
Roque, interim CFO since December 2025, has over 25 years at BD in senior finance roles. He advances the New BD strategy and financial performance.
See the latest news and media coverage for BD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical technology company
bd.comLast updated
In short: BD completed the $4 billion combination of its Biosciences and Diagnostic Solutions with Waters Corporation and raised its fiscal 2026 EPS guidance.
Roque, interim CFO since December 2025, has over 25 years at BD in senior finance roles. He advances the New BD strategy and financial performance.
Revenue reaches $4.7 billion, up 5.2% reported. Adjusted EPS is $2.90. Raises full-year adjusted EPS guidance. Executes $2.0 billion share repurchase.
Wellstar integrates BD Pyxis™ Pro and Alaris™ platforms for enhanced clinician accuracy, real-time visibility, and streamlined workflows to improve patient safety.
The all-in-one central venous catheter device simplifies placement, reduces steps by 30%, cuts insertion time by 50%, and enhances patient safety. It received FDA clearance.
Following this transaction, the insider now owns 21,084 shares of the company. Becton Dickinson & Co (BDX) is a global medical technology company that develops...
Becton (BDX) quarterly earnings analysis examines AI-driven demand, earnings forecasts, and technical momentum with institutional investor focus and future outlook. Becton Dickinson (BDX) reported ...
Display cases feature the glass syringes that founders Maxwell Becton and Fairleigh Dickinson...
Becton Dickinson & Co_ logo on phone-by T_Schneider via Shutterstock Becton, Dickinson and Company...
Track BD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BD and other trending companies.